Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Clopidogrel recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Clopidogrel (7 total). Check the affected lots below.

Most common reason: cGMP deviation (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Clopidogrel. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Clopidogrel recalls on record

none so far in 2026; 7 on record, newest first
Class II · Moderate risk

Clopidogrel Tablets USP

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Ongoing cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-8190-9 D-0513-2023
Class II · Moderate risk

Clopidogrel Tablets USP

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-218-10 D-0380-2023
Class II · Moderate risk

Clopidogrel Tablets

Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 55111-671-31 D-0294-2019
Class II · Moderate risk

Clopidogrel Tablets

Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 55111-671-31 D-0283-2019
Class I · High risk

Clopidogrel Tablets

LABELING: LABEL MIX-UP. Simvastatin tablets, USP 10 mg were found in bottles labeled as Clopidogrel tablets, USP 75 mg.

Terminated Labeling / mix-up International Laboratories, LLC NDC 54458-888-16 D-0472-2018
Class II · Moderate risk

Clopidogrel Bisulfate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-597-2015